Clinical Trial Update: Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of asfotase alfa in patients with hypophosphatasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• Asfotase alfa (asfotase alfa)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Hypophosphatasia | Phase 2 | Status: COMPLETED